Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

• Status: Completed
• Trial end date: 2003-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Study to learn if the alternate formulation is effective in agitated schizophrenic patients

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
• Treatments: Aripiprazole

Criteria

Inclusion Criteria:

• Agitated schizophrenic patients